A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer
ADDICT
A Multicenter Randomized Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer
1 other identifier
interventional
1,880
1 country
50
Brief Summary
In oncological aspect, D1+ lymph node dissection would be enough for early stage gastric cancer in advanced gastric cancer (stage IB/IIA/IIB ).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jan 2014
Longer than P75 for phase_3
50 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 4, 2014
CompletedFirst Posted
Study publicly available on registry
May 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedApril 20, 2016
April 1, 2016
7.9 years
March 4, 2014
April 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
overall survival
To test non-inferiority of survival of D1+ gastrectomy versus D2 gastrectomy for clinical stage I B \& II advanced gastric cancer
5 year
Secondary Outcomes (8)
disease free survival
3 year
Subgroup analysis of Laparoscopic surgery versus open surgery
3 year , 5 year
Operating time
op day
Early postoperative complications
within 30 days
Long term postoperative complications
after 30 days
- +3 more secondary outcomes
Study Arms (2)
D2 distal subtotal gastrectomy
ACTIVE COMPARATORD2 distal subtotal gastrectomy D2 includes Nos.1.3,4sb,4d,5,6,7,8a,9,11p,and 12a nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy
D1+ distal subtotal gastrectomy
EXPERIMENTALD1+ distal subtotal gastrectomy D1+ includes Nos.1,3,4sb,4d,5,6,7,8a,and 9 nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy
Interventions
D2 includes Nos.1.3,4sb,4d,5,6,7,8a,9,11p,and 12a nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.
D1+ includes Nos.1,3,4sb,4d,5,6,7,8a,and 9 nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy
Eligibility Criteria
You may qualify if:
- Histologically proven primary gastric adenocarcinoma
- T1N1, T2N0, T2N1, T3N0, T3N1 by CT scan (AJCC 7th classification) and intraoperative surgical staging prior to resectional procedure
- Location of primary tumor; antrum, or angle, lower body or mid body of the stomach
- No evidence of other distant metastasis
- Aged ≥ 20 year old
- Performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale
- No prior treatment of chemotherapy or radiation therapy against any other malignancies, and no prior treatment for gastric cancer including endoscopic mucosal resection
- Adequate organ functions defined as indicated below:
- WBC 3000/mm3 - 12,000/mm3
- \>serum Hemoglobin 8.0 g/dl
- \> serum Platelet 100 000/mm3
- \< serum AST 100 IU/l
- \<serum ALT 100 IU/l
- \< Total Bilirubin 2.0 mg/dl
- Written signed informed consent
You may not qualify if:
- Active double cancer (synchronous double cancer and metachronous double cancer within five disease-free years), excluding carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer)
- Gastric remnant cancer
- ≥T4a in surgical staging before resection
- N2 or more (number of metastatic lymph nodes ≥3) in CT scan
- Histologically rare variants in WHO Classification such as Adenosquamous, Hepatoid, Squamous cell, Undifferentiated, , neuroendocrine carcinoma and others
- Pregnant or breast-feeding women
- Mental disorder(diagnosed with mental disorder on medical record)
- systemic administration of corticosteroids(include Herbal Medication)
- unstable angina or myocardial infarction within 6 months of the trial
- unstable hypertension
- severe respiratory disease requiring continuous oxygen therapy
- previous upper abdominal surgery except laparoscopic cholecystectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (50)
Kosin University Gospel Hospital
Busan, Busan, 602-702, South Korea
Pusan National University Hospital
Busan, Busan, 602-739, South Korea
Dong-A University Hospital
Busan, Busan, 602-812, South Korea
Dongnam Inst. Of Radiological & Medical Sciences
Busan, Busan, 619-953, South Korea
Inje University Haeundae Paik Hospital
Busan, Busan, Busan 612-896, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, Chuncheongnam-Do, 330-721, South Korea
Keimyung University Dongsan Medical Center
Daegu, Daegu, 700-712, South Korea
Kyungpook National University Hospital
Daegu, Daegu, 700-721, South Korea
Kungpook National University Hospital
Daegu, Daegu, 702-210, South Korea
Daegu Veterans Hospital
Daegu, Daegu, 704-802, South Korea
Yeungnam University Medical Center
Daegu, Daegu, 705-703, South Korea
Daegu Catholic Univ. Medical Center
Daegu, Daegu, 705-718, South Korea
Chungnam National University Hospital
Daejeon, Daejeon, 301-721, South Korea
Konyang University Hospital
Metropolitan City Daejon, Daejon, 302-718, South Korea
Kangwon National University Hospital
Chuncheon, Gangwon-do, 200-722, South Korea
Korea University Ansan Hospital
Ansan, Gyeonggi-do, 425-707, South Korea
Dongguk University Medical Center
Goyang-si, Gyeonggi-do, 410-773, South Korea
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, 471-701, South Korea
The Catholic University of Korea St. Vincent's Hospital
Suwon, Gyeonggi-do, 442-723, South Korea
Ajou University Hospital
Suwon, Gyeonggi-do, 443-380, South Korea
Dongguk University Gyeongju Hospital
Gyeongju, Gyeongsangbuk-do, 780-350, South Korea
Gyengsang National University Hospital
Jinjoo, Gyeongsangnam-do, 660-702, South Korea
National Cancer Center
Goyang, Gyunggi-Do, 410-769, South Korea
Inha University Hospital
Incheon, Incheon, 400-711, South Korea
The Catholic University of Korea Incheon St. Mary's Hospital
Incheon, Incheon, 403-720, South Korea
Gachon University Gill Medical Center
Incheon, Incheon, 405-760, South Korea
Jeju National University Hospital
Jeju City, Jeju Special Self-Governing Province, 690-767, South Korea
Chonbuk National University Hospital
Jeonju, Jellabuk-Do, 561-712, South Korea
Chosun University Hospital
Gwangju, Jellanam-Do, 501-717, South Korea
Chonnam National University Hwasun Hospital
Hwasun-Gun, Jellanam-Do, 519-763, South Korea
Seoul National University Hospital
Seoul, Seoul, 110-744, South Korea
Seoul Red Cross Hospital
Seoul, Seoul, 110-747, South Korea
Severance Hospital
Seoul, Seoul, 120-752, South Korea
KyungHee University Medical Center
Seoul, Seoul, 130-872, South Korea
Hanyang University Medical Center
Seoul, Seoul, 133-792, South Korea
Kyung Hee University Hospital at Gangdong
Seoul, Seoul, 134-727, South Korea
VHS Medical Center
Seoul, Seoul, 134-791, South Korea
Samsung Medical Center
Seoul, Seoul, 135-710, South Korea
Gangnam Severance Hospital
Seoul, Seoul, 135-720, South Korea
Korea University Anam Hospital
Seoul, Seoul, 136-705, South Korea
The Catholic University of Korea St. Mary's Hospital
Seoul, Seoul, 137-701, South Korea
Asan Medical Center
Seoul, Seoul, 138-736, South Korea
Korea Cancer Center Hospital
Seoul, Seoul, 139-709, South Korea
Soon Chun Hyang University Hospital Seoul
Seoul, Seoul, 140-887, South Korea
Konkuk University Medical Center
Seoul, Seoul, 143-729, South Korea
Hallym University Sacred Heart Hospital
Seoul, Seoul, 150-037, South Korea
Korea University Guro Hospital
Seoul, Seoul, 152-703, South Korea
SMG-SNU Boramae Medical Center
Seoul, Seoul, 156-707, South Korea
Chung-Ang University Hospital
Seoul, Seoul, 156-755, South Korea
Ewha Womans University Medical Center
Seoul, Seoul, 158-710, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Young Woo Kim, PhD
National Cancer Center, Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Gastric Cancer Branch
Study Record Dates
First Submitted
March 4, 2014
First Posted
May 22, 2014
Study Start
January 1, 2014
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
April 20, 2016
Record last verified: 2016-04